The indicators are toppy at present. But it's a strategy to aim for if it comes to fruition on confirmation. Any further retrace of price would void present pattern.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025